TGTX vs. AVPT
TGTX (TG Therapeutics, Inc.) and AVPT (AvePoint, Inc.) are both stocks. TGTX operates in Biotechnology (Healthcare), while AVPT operates in Software - Infrastructure (Technology). Over the past 5 years, TGTX returned 8.26%/yr vs 4.31%/yr for AVPT. Their 0.31 correlation means their historical movements had little consistent relationship.
Performance
TGTX vs. AVPT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TGTX achieves a 74.54% return, which is significantly higher than AVPT's -6.19% return.
TGTX
- 1D
- -2.80%
- 1M
- -2.78%
- 6M
- 76.79%
- YTD
- 74.54%
- 1Y
- 46.56%
- 3Y*
- 70.54%
- 5Y*
- 8.26%
- 10Y*
- 24.71%
- ALL TIME*
- -7.87%
AVPT
- 1D
- 1.64%
- 1M
- 13.90%
- 6M
- 12.04%
- YTD
- -6.19%
- 1Y
- -31.71%
- 3Y*
- 28.30%
- 5Y*
- 4.31%
- 10Y*
- —
- ALL TIME*
- 1.55%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
AVPT AvePoint, Inc. | $27.40M | $28.43M | $27.56M |
| $111.05M | $115.82M | $119.77M |
TGTX vs. AVPT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
TGTX TG Therapeutics, Inc. | 74.54% | -0.96% | 76.23% | 44.38% | -37.74% | -53.03% |
AVPT AvePoint, Inc. | -6.19% | -15.87% | 101.10% | 99.76% | -34.66% | -47.80% |
Correlation
The correlation between TGTX and AVPT is 0.11, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.11 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.32 |
Correlation (All Time) Calculated using the full available price history since Jul 2, 2021 | 0.31 |
Over the past year, the correlation between TGTX and AVPT has dropped to 0.11 - well below their long-term average of 0.31, suggesting their price drivers have been diverging.
Fundamentals
TGTX:
$7.96B
AVPT:
$2.76B
TGTX:
$2.88
AVPT:
$0.20
TGTX:
18.04
AVPT:
64.32
TGTX:
0.03
AVPT:
0.42
TGTX:
11.90
AVPT:
6.76
TGTX:
14.28
AVPT:
6.71
TGTX:
$700.35M
AVPT:
$443.68M
TGTX:
$581.54M
AVPT:
$326.90M
TGTX:
$156.88M
AVPT:
$53.29M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TGTX vs. AVPT — Risk / Return Rank
TGTX
AVPT
TGTX vs. AVPT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and AvePoint, Inc. (AVPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TGTX | AVPT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.68 | ||
| Sortino ratioReturn per unit of downside risk | +2.37 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 0.90 | +0.31 |
| Calmar ratioReturn relative to maximum drawdown | 1.74 | -0.62 | +2.36 |
| Martin ratioReturn relative to average drawdown | 3.46 | -0.94 | +4.40 |
Loading charts...
Drawdowns
TGTX vs. AVPT - Drawdown Comparison
The maximum TGTX drawdown since its inception was -99.52%, which is greater than AVPT's maximum drawdown of -70.21%. Use the drawdown chart below to compare losses from any high point for TGTX and AVPT.
Loading charts...
Drawdown Indicators
| TGTX | AVPT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.52% | -70.21% | -29.31% |
Max Drawdown (1Y)Largest decline over 1 year | -26.85% | -51.11% | +24.26% |
Max Drawdown (3Y)Largest decline over 3 years | -42.06% | -55.03% | +12.97% |
Max Drawdown (5Y)Largest decline over 5 years | -89.47% | -66.70% | -22.77% |
Max Drawdown (10Y)Largest decline over 10 years | -93.19% | — | — |
Current DrawdownCurrent decline from peak | -77.71% | -34.82% | -42.89% |
Average DrawdownAverage peak-to-trough decline | -91.31% | -36.49% | -54.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.66% | 35.98% | -22.32% |
Volatility
TGTX vs. AVPT - Volatility Comparison
The current volatility for TG Therapeutics, Inc. (TGTX) is 12.23%, while AvePoint, Inc. (AVPT) has a volatility of 12.93%. This indicates that TGTX experiences smaller price fluctuations and is considered to be less risky than AVPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TGTX | AVPT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.23% | 12.93% | -0.70% |
Volatility (6M)Calculated over the trailing 6-month period | 33.96% | 33.51% | +0.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.22% | 46.44% | +0.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.68% | 46.30% | +41.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.71% | 46.70% | +40.01% |
Dividends
TGTX vs. AVPT - Dividend Comparison
Neither TGTX nor AVPT has paid dividends to shareholders.
Financials
TGTX vs. AVPT - Financials Comparison
This section allows you to compare key financial metrics between TG Therapeutics, Inc. and AvePoint, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TGTX vs. AVPT - Profitability Comparison
TGTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.
AVPT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, AvePoint, Inc. reported a gross profit of 85.37M and revenue of 117.24M. Therefore, the gross margin over that period was 72.8%.
TGTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.
AVPT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, AvePoint, Inc. reported an operating income of 12.73M and revenue of 117.24M, resulting in an operating margin of 10.9%.
TGTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.
AVPT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, AvePoint, Inc. reported a net income of 15.25M and revenue of 117.24M, resulting in a net margin of 13.0%.
Frequently Asked Questions
TGTX and AVPT have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVPT has higher volatility (12.93%) compared to TGTX (12.23%). In terms of maximum drawdown, TGTX dropped -99.52% vs AVPT's -70.21%.
TGTX currently has the higher Sharpe Ratio (0.99 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TGTX and AVPT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer